8-144515746-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004260.4(RECQL4):​c.1258+18G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.46 in 1,610,022 control chromosomes in the GnomAD database, including 175,331 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.40 ( 13513 hom., cov: 34)
Exomes 𝑓: 0.47 ( 161818 hom. )

Consequence

RECQL4
NM_004260.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.296

Publications

24 publications found
Variant links:
Genes affected
RECQL4 (HGNC:9949): (RecQ like helicase 4) The protein encoded by this gene is a DNA helicase that belongs to the RecQ helicase family. DNA helicases unwind double-stranded DNA into single-stranded DNAs and may modulate chromosome segregation. This gene is predominantly expressed in thymus and testis. Mutations in this gene are associated with Rothmund-Thomson, RAPADILINO and Baller-Gerold syndromes. [provided by RefSeq, Jan 2010]
RECQL4 Gene-Disease associations (from GenCC):
  • Baller-Gerold syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet
  • Rothmund-Thomson syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Rothmund-Thomson syndrome type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
  • osteosarcoma
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • rapadilino syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 8-144515746-C-T is Benign according to our data. Variant chr8-144515746-C-T is described in ClinVar as Benign. ClinVar VariationId is 94884.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.563 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RECQL4NM_004260.4 linkc.1258+18G>A intron_variant Intron 6 of 20 ENST00000617875.6 NP_004251.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RECQL4ENST00000617875.6 linkc.1258+18G>A intron_variant Intron 6 of 20 1 NM_004260.4 ENSP00000482313.2

Frequencies

GnomAD3 genomes
AF:
0.396
AC:
60246
AN:
152020
Hom.:
13508
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.174
Gnomad AMI
AF:
0.269
Gnomad AMR
AF:
0.509
Gnomad ASJ
AF:
0.419
Gnomad EAS
AF:
0.469
Gnomad SAS
AF:
0.581
Gnomad FIN
AF:
0.500
Gnomad MID
AF:
0.415
Gnomad NFE
AF:
0.471
Gnomad OTH
AF:
0.427
GnomAD2 exomes
AF:
0.475
AC:
115771
AN:
243622
AF XY:
0.480
show subpopulations
Gnomad AFR exome
AF:
0.160
Gnomad AMR exome
AF:
0.559
Gnomad ASJ exome
AF:
0.445
Gnomad EAS exome
AF:
0.467
Gnomad FIN exome
AF:
0.492
Gnomad NFE exome
AF:
0.469
Gnomad OTH exome
AF:
0.464
GnomAD4 exome
AF:
0.467
AC:
680732
AN:
1457884
Hom.:
161818
Cov.:
50
AF XY:
0.471
AC XY:
341381
AN XY:
724960
show subpopulations
African (AFR)
AF:
0.158
AC:
5302
AN:
33452
American (AMR)
AF:
0.548
AC:
24316
AN:
44334
Ashkenazi Jewish (ASJ)
AF:
0.435
AC:
11319
AN:
26046
East Asian (EAS)
AF:
0.416
AC:
16479
AN:
39596
South Asian (SAS)
AF:
0.563
AC:
48327
AN:
85882
European-Finnish (FIN)
AF:
0.493
AC:
25621
AN:
51980
Middle Eastern (MID)
AF:
0.357
AC:
2057
AN:
5758
European-Non Finnish (NFE)
AF:
0.468
AC:
519965
AN:
1110584
Other (OTH)
AF:
0.454
AC:
27346
AN:
60252
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
20256
40512
60769
81025
101281
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15356
30712
46068
61424
76780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.396
AC:
60267
AN:
152138
Hom.:
13513
Cov.:
34
AF XY:
0.403
AC XY:
29989
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.174
AC:
7217
AN:
41540
American (AMR)
AF:
0.510
AC:
7810
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.419
AC:
1454
AN:
3472
East Asian (EAS)
AF:
0.469
AC:
2420
AN:
5162
South Asian (SAS)
AF:
0.581
AC:
2804
AN:
4826
European-Finnish (FIN)
AF:
0.500
AC:
5294
AN:
10578
Middle Eastern (MID)
AF:
0.422
AC:
124
AN:
294
European-Non Finnish (NFE)
AF:
0.471
AC:
31996
AN:
67932
Other (OTH)
AF:
0.427
AC:
903
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1770
3540
5309
7079
8849
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
570
1140
1710
2280
2850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.455
Hom.:
26392
Bravo
AF:
0.385
Asia WGS
AF:
0.540
AC:
1877
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
May 08, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Rapadilino syndrome Benign:2
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2025
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Rothmund-Thomson syndrome type 2 Benign:2
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Baller-Gerold syndrome Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
4.4
DANN
Benign
0.64
PhyloP100
0.30
PromoterAI
0.035
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4251689; hg19: chr8-145741130; COSMIC: COSV52879960; COSMIC: COSV52879960; API